The company is significantly boosted its progress of an new solution for ATTR-CM, leveraging the compound. Early patient data indicates promising outcomes for patients diagnosed with this debilitating condition. The https://attrcm099427.blogdigy.com/bridgebio-improves-amyloidosis-management-using-attruby-68366428